Skip to main
AHR
AHR logo

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. demonstrated robust financial performance, characterized by a 4.1% year-over-year growth in rental rates and exceptional same-store NOI growth, particularly with the SHOP segment expanding by 25.3% and ISHC by 21.7%. The REIT has achieved the highest FFO growth rate within the Healthcare REIT sector, driven by favorable industry dynamics and proactive management strategies, especially after obtaining a superior cost of capital in late 2024. This advantageous position allows American Healthcare REIT to pursue aggressive investments, yielding projected two-year CAGR of 11.8% for Trilogy and 15.5% for SHOP, thereby enhancing its organic growth trajectory.

Bears say

American Healthcare REIT Inc. is facing a challenging outlook due to potential economic headwinds and regulatory changes that may adversely affect its tenants' operational performance, impacting the REIT's ability to meet earnings expectations. While leverage has decreased to 28.8% and net debt to annualized EBITDA has improved to 3.7x as of 2Q25, these metrics indicate financial stress and highlight an ongoing concern regarding the REIT's liquidity and ability to reinvest in properties. Additionally, the risk of lower Medicaid rates could significantly hinder growth prospects, suggesting a wary environment for future investments and earnings potential.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.